OOIR: Observatory of International Research

Papers

(The H4-Index of Trends in Molecular Medicine is 48. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Advisory Board and Contents	231
Subscription and Copyright Information	230
Advisory Board and Contents	223
Subscription and Copyright Information	208
Advisory Board and Contents	196
The right drug at the right time: key to IBD success	150
Subscription and Copyright Information	130
Subscription and Copyright Information	128
m6A and beyond: RNA modifications shaping angiogenesis	126
Cellular senescence in neuroinflammatory disease: new therapies for old cells?	122
Pushing the boundaries of brain organoids to study Alzheimer’s disease	117
Beneath the radar: immune-evasive cell sources for stroke therapy	111
Bursts of brain erosion: seizures and age-dependent neurological vulnerability	100
Opportunities and challenges for biomarker discovery using electronic health record data	100
Consideration of the importance of measuring thermal discomfort in biomedical research	96
Lymph node microenvironment rewires ferroptosis redox defenses	95
Microbiota: a dawn for cancer metastasis therapy	92
Muscle-to-CNS signaling in physiological homeostasis, aging, and disease	91
Hyperemesis gravidarum theories dispelled by recent research: a paradigm change for better care and outcomes	88
Fc-optimized checkpoint antibodies for cancer immunotherapy	86
d-Amino acids: new clinical pathways for brain diseases	85
Neutrophils and extracellular traps in crystal-associated diseases	81
Advancements in intensive eating disorder treatments: the benefit of CBT-E and integrated care models	78
Amyloid and collagen templates in aortic valve calcification	75
Engineering cytokines for tumor-targeting and selective T cell activation	73

Insights from HIV-1 vaccine and passive immunization efficacy trials	72
Molecular mechanisms in the pathogenesis of dengue infections	71
Advisory Board and Contents	67
Emerging roles of cyclin-dependent kinase 7 in health and diseases	67
Subscription and Copyright Information	65
Brain-specific regulatory T cell expansion limits cognitive decline	65
Erythropoietic protoporphyrias: updates and advances	62
Systemically administered alcadein peptide p3-Alcβ neutralizes brain Alzheimer’s Aβ oligomers	62
HDAC inhibitors as pharmacological treatment for Duchenne muscular dystrophy: a discovery journey from bench to patients	61
Manipulating the gut and tumor microbiota for immune checkpoint inhibitor therapy: from dream to reality	60
Acquired resistance to immunotherapy in solid tumors	56
Hormesis as an adaptive response to infection	54
Microbes and mood: innovative biomarker approaches in depression	54
Is endometriosis a progressive disease?	53
SOX17: escape route from immune destruction in early CRC	52
Keratinocytes: new perspectives in inflammatory skin diseases	52
Epigenetic regulation in intervertebral disc degeneration	52
Subscription and Copyright Information	52
RNA immunotherapy: revolutionizing cancer and autoimmune disease treatments	52
Strategies and challenges for non-viral delivery of non-coding RNAs to the heart	52
Three ‘E’ challenges for siRNA drug development	52
Shining a light on comorbidities	50
Subscription and Copyright Information	49
Advisory Board and Contents	48